A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Clinical trial NCT07282613 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07282613
- Sponsor
- Novo Nordisk A/S
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-04
- Primary completion
- 2029-09-07
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.